{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:52:37Z","timestamp":1777384357234,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T00:00:00Z","timestamp":1468108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Hosp Palliat Care"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>Opioid-related bowel dysfunction is a common and potentially severe adverse effect from treatment with opioid analgesics. Its development is not dose related, nor do patients develop tolerance. Opioid-induced constipation (OIC) can lead to fecal impaction, bowel obstruction, and bowel perforation as well as noncompliance with opioid analgesics and poor quality of life. Routine administration of laxatives is necessary to maintain bowel function, and, in refractory cases, other modalities must be pursued. Available options are limited but include peripherally acting \u03bc-opioid receptor antagonists (PAMORAs), including methylnaltrexone. Naloxegol is a newly developed PAMORA that is available through the oral route. At the therapeutic dose of 25 mg daily, naloxegol is effective and safe, with a limited side effect profile and is associated with preservation of centrally mediated analgesia. In this article, we discuss the pharmacokinetics, pharmacodynamics, adverse effects, clinical trials, and cost considerations of naloxegol. Finally, we discuss its potential role as a novel key treatment for OIC in palliative medicine patients.<\/jats:p>","DOI":"10.1177\/1049909115593937","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T21:00:41Z","timestamp":1436216441000},"page":"875-880","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Naloxegol"],"prefix":"10.1177","volume":"33","author":[{"given":"Rachel","family":"Jones","sequence":"first","affiliation":[{"name":"Mayo Clinic Arizona, Palliative Medicine, Phoenix, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Prommer","sequence":"additional","affiliation":[{"name":"Mayo Clinic Arizona, Palliative Medicine, Phoenix, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Backstedt","sequence":"additional","affiliation":[{"name":"Banner University Medical Center, Gastroenterology, Phoenix, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,7,10]]},"reference":[{"key":"bibr1-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(02)00424-4"},{"key":"bibr2-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310246"},{"key":"bibr3-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.349"},{"key":"bibr4-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00782-6"},{"key":"bibr5-1049909115593937","unstructured":"AstraZeneca Pharmaceuticals. Movantik U.S. Prescribing Information; 2015:1-6. Web site. http:\/\/www.astrazeneca-us.com. Published January 2015. Updated January 2015. Accessed February 22, 2015."},{"key":"bibr6-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12443"},{"key":"bibr7-1049909115593937","unstructured":"AstraZeneca Pharmaceuticals. Naloxegol Briefing Document for the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC). 2014:1\u201372. Web site. http:\/\/www.fda.gov\/downloads\/\u2026\/UCM400209. Published May 06, 2014. Accessed September15, 2014."},{"key":"bibr8-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.04.024"},{"key":"bibr9-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.348"},{"key":"bibr10-1049909115593937","unstructured":"U.S. Food and Drug Administration. Drug Development and Drug Interactions: Table of Substrates, Inhibitors, and Inducers; 2006. Web site. http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm093664.htm. Accessed January 11, 2015."},{"key":"bibr11-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12899"},{"key":"bibr12-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.09.019"},{"key":"bibr13-1049909115593937","unstructured":"Mayo Clinic Arizona Pharmacy Data; 2015."},{"key":"bibr14-1049909115593937","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707377"}],"container-title":["American Journal of Hospice and Palliative Medicine\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1049909115593937","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1049909115593937","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1049909115593937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:29:46Z","timestamp":1777368586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1049909115593937"}},"subtitle":["A Novel Therapy in the Management of Opioid-Induced Constipation"],"short-title":[],"issued":{"date-parts":[[2016,7,10]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1177\/1049909115593937"],"URL":"https:\/\/doi.org\/10.1177\/1049909115593937","relation":{},"ISSN":["1049-9091","1938-2715"],"issn-type":[{"value":"1049-9091","type":"print"},{"value":"1938-2715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,10]]}}}